(2025)
Population structure in a fungal human pathogen is potentially linked to pathogenicity.
Nat Commun 16(1),
7594.
Oliver Kurzai
National Reference Center for Invasive Fungal Infections · Head Fungal Septomics · Head +49 931 31-46161 oliver.kurzai@uni-wuerzburg.deCurriculum vitae
Main Research Areas
- Infection biology of human pathogenic fungi (especially Candida albicans)
- Infection biology of Neisseria meningitidis
Professional Career
| Since 2017 | Chair of Medical Microbiology and Mycology, Institute for Hygiene and Microbiology, Julius Maximilians University Würzburg and head of the research group Fungal Septomics at Leibniz Institute for Natural Product Research and Infection Biology – Hans-Knöll-Institute Jena |
| 2009-2016 | Professor (W2) for Fungal Septomics, Friedrich-Schiller-University Jena |
| 2008 | Habilitation in medical microbiology, University Würzburg |
| 2006 | Medical specialist in microbiology, virology and infection epidemiology (Bayerische Landesärztekammer) |
| 2003 | Head of a working group, Institut für Hygiene und Mikrobiologie, University Würzburg |
| 2001-2002 | Doctor in practical training (AiP), Institut für Hygiene und Mikrobiologie, University Würzburg |
| 2002 | Dr. med., “summa cum laude” University Würzburg |
| 2001 | Staatsexamen (state examination) in human medicine, University Würzburg |
Awards · Appointments · Scientific Activities
| Since 2014 | Head of the Nationales Referenzzentrums für invasive Pilzinfektionen (NRZMyk) |
| Since 2013 | Board member of the Integriertes Forschungs- und Behandlungszentrum “Center for Sepsis Control and Care” (CSCC) at the University Hospital Jena |
| Since 2012 | Scientific Manager of the consortium “InfectControl 2020 – New Antiinfection Strategies – Science • Society • Economy” within the BMBF-Programme “Zwanzig 20 – Partnership for Innovation” (Head: Prof. A. Brakhage) |
| Since 2012 | Editor-in-chief, Medical Mycology Case Reports, member (ex officio) of the executive board of the International Society for Human & Animal Mycology (ISHAM) |
| Since 2011 | Elected note taker at the Deutschsprachige Mykologische Gesellschaft DMykG |
| 2015-2016 | Speaker of the ZIK Septomics |
| 2011-2013 | Editor, Journal of Basic Microbiology |
| 2009 | Hans-Rieth-poster prize from the Deutschsprachige Mykologische Gesellschaft (DMykG) |
| 2008 | Award from the Deutsche Gesellschaft für Hygiene und Mikrobiologie |
| 2003 | Science award from the Unterfränkische Gedenkjahrstiftung |
| 2003 | Dissertation award from the medical faculty of the University Würzburg |
| 2002 | Becton-Dickinson PhD award from the Deutsche Gesellschaft für Hygiene und Mikrobiologie |
Publications
(2025)
Unveiling immune interference: how the dendritic cell response to co-infection with Aspergillus fumigatus is modulated by human cytomegalovirus and its virokine CMVIL-10.
mBio 16(11),
e0154125.
(2025)
Dipsticks and point-of-care microscopy in urinary tract infections in primary care: Results of the MicUTI pilot cluster randomised controlled trial.
PLoS One 20(10),
e0332390.
(2025)
Elevating fungal care: bridging Brazil's healthcare practices to global standards.
Microbiol Spectr 13(4),
e0211224.
(2025)
Localized versus diffuse corneal invasion in fungal keratitis: Histological insights from Candida albicans and Fusarium falciforme.
J Fungi 11(9),
688.
(2025)
[S1 guideline: diagnosis and treatment of invasive pulmonary aspergillosis in critically ill/intensive care patients].
Med Klin Intensivmed Notfmed 120(4),
271-289.
(Review)
(2025)
Diagnosis and treatment of invasive pulmonary aspergillosis in critically ill intensive care patients: executive summary of the German national guideline (AWMF 113-005).
Infection 53(4),
1299-1310.
(Review)
(2025)
Development and evaluation of a massive open online course (MOOC) to teach medical students the prudent use of antibiotics.
Antimicrob Resist Infect Control 14(1),
105.
(2025)
A 3D Fusarium keratitis model reveals isolate-specific adhesion and invasion properties in the Fusarium solani species complex.
mSphere 10(11),
e0032825.
(2024)
Zunahme von Candida auris in Deutschland im Jahr 2023.
Epidemiologisches Bulletin (18),
3-7.